Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Harvard Business School
Cantor Fitzgerald

Generated: June 26, 2017

DrugPatentWatch Database Preview

Ceftriaxone sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for ceftriaxone sodium and what is the scope of ceftriaxone sodium patent protection?

Ceftriaxone sodium
is the generic ingredient in seven branded drugs marketed by Qilu Pharm Co Ltd, Aurobindo Pharma Ltd, Sandoz Inc, Akorn Inc, Roche, Sagent Pharms, Baxter Hlthcare, Hoffmann La Roche, Lupin, Teva Pharms Usa, Acs Dobfar, Hospira Inc, Hikma Farmaceutica, Fresenius Kabi Usa, Samson Medcl, Teva, Bedford, Agila Speclts, Sandoz, Facta Farma, Wockhardt, Cephazone Pharma, and B Braun, and is included in thirty-eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for ceftriaxone sodium. Twenty-five suppliers are listed for this compound.

Summary for Generic Name: ceftriaxone sodium

Drug Master File Entries: see list23
Suppliers / Packagers: see list25
Bulk Api Vendors: see list81
Clinical Trials: see list2,440
Patent Applications: see list7,372
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ceftriaxone sodium at DailyMed

Pharmacology for Ingredient: ceftriaxone sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065169-001May 9, 2005APRXNoYes► Subscribe► Subscribe
Hospira Inc
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065230-001Aug 2, 2005APRXNoNo► Subscribe► Subscribe
Hikma Farmaceutica
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065342-002Jan 10, 2008APRXNoNo► Subscribe► Subscribe
Acs Dobfar
ceftriaxone sodium
INJECTABLE;INJECTION065329-001Jul 24, 2008APRXNoNo► Subscribe► Subscribe
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065169-003May 9, 2005APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus